Kaken Pharmaceutical Co., Ltd.

Kaken Pharmaceutical Co., Ltd. produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally. Its pharmaceutical and medical device portfolio includes Clenafin for onychomycosis, Artz for osteoarthritis, Fiblast for wound healing, Ecclock for primary axillary hyperhidrosis, Regroth for periodontal regeneration, Hernicore for lumbar disc herniation, and Seprafilm, an adhesion barrier used in surgery and gynecology. The company also offers agrochemicals and animal health products, such as Polyoxins fungicides, Pentoxazone and Metamifop rice herbicides, Salinomycin for chickens, and Uroston for cattle. Its development pipeline includes KMW-1, KAR, KP-001, Seladelpar, KP-483, NM26-2198, KP-910, and Tildacerfont. Additionally, it rents Bunkyo Green Court and has a collaboration and licensing agreement with Alumis Inc. for ESK-001 in Japan. Founded in 1917, the company is headquartered in Tokyo, Japan.